Arca
Skip to content

Infant Phototherapy Equipment

Unit, Neonatal Phototherapy. 510(k) K210289, from Bistos Co., Ltd. (Seongnam-Si, KR). Product code LBI, class 2.

As of Nov 16, 2026, K210289 is an FDA 510(k) held by Bistos Co., Ltd., substantially equivalent on May 28, 2021 after 115 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: May 28, 2021
  • Review time: 115 days
  • Recalls: 0
  • Cited as a predicate by: 2 devices

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The BiliTouch™, model Motif Phototherapy Blanket and Infant Phototherapy Equipment, model BT-450 are indicated for use to treatment of infants diagnosed with hyperbilirubinemia, commonly known as neonatal jaundice, which can cause a yellow discoloration of the skin and the whites of the eyes. The devices can be used in a hospital or at home.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a Predicate

2 later 510(k) summaries name this device as a predicate

Other LBI Clearances

The newest 510(k)s for the same product code; see every LBI device

Record

Type
Traditional, third-party review
Received
Feb 2, 2021
Review panel
General Hospital
Regulation
21 CFR 880.5700

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.